Obesity

 
Daily Dose: Semaglutide Not Linked to Suicide Ideation
January 18, 2024

Your daily dose of the clinical news you may have missed.

More Childhood Stress Linked to Increased Risk for Cardiometabolic Disease
January 17, 2024

Findings from new study suggest that promoting healthy coping strategies for stress during early life can reduce cardiometabolic risk, report researchers.

Early Breastfeeding May Reduce Risk of Childhood Obesity, Regardless of Mother's BMI: NIH Study
January 16, 2024

Each additional month of breastfeeding beyond 3 months correlated with a significantly lower child BMIz, especially for mothers identified as overweight or obese.

Daily Dose: NAFLD Associated with Adverse Outcomes Regardless of BMI
January 16, 2024

Your daily dose of the clinical news you may have missed.

Consuming More Food, Beverages with Added Sugar Linked to Greater Risk for Metabolic Syndrome
January 15, 2024

Compared to the lowest intake of AS-rich food and beverages, the highest intake was associated with a 59% higher risk of developing MetS, according to new findings.

FDA Review Suggest No Link Between GLP-1RAs and Suicidal Thoughts but Surveillance Will Continue
January 12, 2024

While the FDA's preliminary evaluation has not surfaced evidence of a link, the agency says it "cannot definitively rule out that a small risk may exist," and so will continue research.

Daily Dose: High BMI in Adolescence Linked to CKD in Young Adulthood
January 12, 2024

Your daily dose of the clinical news you may have missed.

Semaglutide Linked to Lower Risk of Suicidal Ideation in Patients with Obesity, Type 2 Diabetes
January 10, 2024

Semaglutide was associated with a lower risk of first-time and recurrent suicidal ideations in patients with obesity or overweight or T2D, according to new study.

Obesity Management: What Clinicians Need to Know in 2024
January 10, 2024

Angela Fitch, MD, president of the Obesity Medicine Association, details what to look forward to this year in terms of obesity management.

NAFLD Linked to Adverse Outcomes Regardless of BMI, New Research Suggests
January 08, 2024

Individuals with "lean NAFLD" may be at similar risk of NASH, cirrhosis, nonliver cancer, and death as as those with NAFLD and overweight or obesity, authors say.